-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: June 2011
BIO, Here We Come!
Angie Drakulich from PharmaTech Talk writes: Next week is the annual Biotechnology Industry Organization (BIO) Convention in Washington, DC. Many of our editorial team members will be there and we hope to see you. With a regulatory pathway for biosimilars underway in the United States, renewed conversations about regenerative medicine, and a booming biotech sector, the convention should be quite dynamic. Angie is part of our BIO Official Blog Program. Keep an eye on her Read More >
BIO Official Bloggers Program: Focus on Biosimilars
Andrew Williams wrote a second part to his original blog entry on 2011 BIO International Convention preview… This time his focus is on Biosimilars: For BIO attendees interested in learning more about the relatively new pathway for FDA approval of biosimilars, also known as follow-on biologics, there are several sessions devoted to the intricacies of the new law, or how the new legislation is impacting the BIO community. The biosimilar framework was introduced last year Read More >
BIOtechNOW: Where the biotech industry meets online
As the biotech industry prepares to meet at the 2011 BIO International Convention in Washington, DC next week, I’m pleased to announce that we’ve re-launched BIOtechNOW as a multi-blog platform. Our new platform aims to create an online biotech community where we can connect to discuss the latest industry news – kind of like our convention, but available online 365 days a year. BIOtechNOW will be a critical component of our advocacy, education and business Read More >
Sickle Cell Anemia: Three ways to help end it
Sickle Cell Anemia is the most common genetic disease in the United States. It affects more than 80,000 people in America and the trait for the disease is known to be carried by one in 12 African Americans. For those living with the disease, suffering from a sickle cell crisis can be debilitating, reducing a person into a state of intense pain, which often means trips to the hospital that typically last six days. There Read More >
Podcast: Dr. Hervé Tettelin on vaccine development
Dr. Tettelin, with the University of Maryland School of Medicine in the Institute for Genome Sciences, discusses his research in reverse vaccinology and as a pioneer of the pan-genome concept. He also discusses how DNA sequencing is evolving and how that impacts vaccine development. Download the podcast
